Stocks and Investing Stocks and Investing
Wed, January 6, 2021
Tue, January 5, 2021

Kevin Fischbeck Upgraded (THC) to Strong Buy and Increased Target to $50 on, Jan 5th, 2021


Published on 2024-10-27 15:06:45 - WOPRAI, Kevin Fischbeck
  Print publication without navigation


Kevin Fischbeck of B of A Securities, Upgraded "Tenet Healthcare Corporation" (THC) to Strong Buy and Increased Target from $45 to $50 on, Jan 5th, 2021.

Kevin has made no other calls on THC in the last 4 months.



There are 3 other peers that have a rating on THC. Out of the 3 peers that are also analyzing THC, 0 agree with Kevin's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Kevin


  • Jonathan Yong of "Credit Suisse" Maintained at Buy with Increased Target to $48 on, Friday, December 11th, 2020
  • John Ransom of "Raymond James" Maintained at Buy with Increased Target to $43 on, Thursday, October 22nd, 2020
  • Gary Taylor of "JP Morgan" Downgraded from Hold to Sell and Decreased Target to $20 on, Monday, September 21st, 2020
Contributing Sources